Structured evidence table for Maca Sleep Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Maca Sleep Randomized Trial | It is associated with increased risk of stroke, heart failure, hospitalization, and mortality, placing a substantial clinical and economic burden on healthcare systems [,]. | 4 | Sokolova Emma (2026) | Integrating Patient-Reported Outcomes into Clinical Pathways in Atrial Fibrillation: A Framework Aligned with the AF-CARE Model |
| Maca Sleep Randomized Trial | For example, studies suggest that up to 30–40% of patients with AF report cognitive complaints or sleep disturbances, both of which are associated with reduced quality of life and increased healthcare utilization [,,,]. | 4 | Sokolova Emma (2026) | Integrating Patient-Reported Outcomes into Clinical Pathways in Atrial Fibrillation: A Framework Aligned with the AF-CARE Model |
| Maca Sleep Randomized Trial | As a result, their potential to inform treatment strategies, guide resource allocation, and improve health system performance remains underused. | 4 | Sokolova Emma (2026) | Integrating Patient-Reported Outcomes into Clinical Pathways in Atrial Fibrillation: A Framework Aligned with the AF-CARE Model |
| Maca Sleep Randomized Trial | 1 2 3 4 5 6 Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia worldwide, affecting an estimated 37–40 million individuals [,]. | 4 | Sokolova Emma (2026) | Integrating Patient-Reported Outcomes into Clinical Pathways in Atrial Fibrillation: A Framework Aligned with the AF-CARE Model |
| Maca Sleep Randomized Trial | By synthesizing molecular evidence from the BDNF/TrkB/CREB signaling axis and the Nrf2/NF-κB homeostatic switch, we demonstrate that this multi-target strategy offers a more robust path to neuronal resilience than traditional single-target approaches. | 4 | Cipriano GL (2026) | Phytochemical and Fungal Bioactive Compounds in the "Brain Health Triad": A Narrative Review on Neurostimulating, Neurotrophic, and Neuroprotective Synergy. |
| Maca Sleep Randomized Trial | This narrative review proposes the 'Brain Health Triad' as a novel integrative framework for neurorehabilitation and cognitive enhancement, built upon three interdependent biological pillars: neurostimulation, neurotrophy, and neuroprotection. | 4 | Cipriano GL (2026) | Phytochemical and Fungal Bioactive Compounds in the "Brain Health Triad": A Narrative Review on Neurostimulating, Neurotrophic, and Neuroprotective Synergy. |
| Maca Sleep Randomized Trial | We illustrate how the synergistic interplay between a 'core triad' composed of Hericium erinaceus , Bacopa monnieri , and L-Theanine targets these pillars with high specificity. | 4 | Cipriano GL (2026) | Phytochemical and Fungal Bioactive Compounds in the "Brain Health Triad": A Narrative Review on Neurostimulating, Neurotrophic, and Neuroprotective Synergy. |
Source documents